Imaging of Anaplastic Thyroid Carcinoma

References

1. 1.↵
   2. Are C,
   3. Shaha AR

   . Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453–64 doi:10.1245/ASO.2006.05.042 pmid:16474910

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Bogsrud TV,
   3. Karantanis D,
   4. Nathan MA, et al

   . 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma. Thyroid 2008;18:713–19 doi:10.1089/thy.2007.0350 pmid:18630999

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Ragazzi M,
   3. Ciarrocchi A,
   4. Sancisi V, et al

   . Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol 2014;2014:790834 doi:10.1155/2014/790834 pmid:25214840

   CrossRefPubMed
4. 4.↵
   2. Smallridge RC,
   3. Ain KB,
   4. Asa SL, et al

   . American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012;22:1104–39 doi:10.1089/thy.2012.0302 pmid:23130564

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Smallridge RC,
   3. Copland JA

   . Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) 2010;22:486–97 doi:10.1016/j.clon.2010.03.013 pmid:20418080

   CrossRefPubMed
6. 6.↵
   2. Rao SN,
   3. Zafereo M,
   4. Dadu R, et al

   . Patterns of treatment failure in anaplastic thyroid carcinoma. Thyroid 2017;27:672–81 doi:10.1089/thy.2016.0395 pmid:28068873

   CrossRefPubMed
7. 7.↵
   2. Aschebrook-Kilfoy B,
   3. Ward MH,
   4. Sabra MM, et al

   . Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid 2011;21:125–34 doi:10.1089/thy.2010.0021 pmid:21186939

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Neff RL,
   3. Farrar WB,
   4. Kloos RT, et al

   . Anaplastic thyroid cancer. Endocrinol Metab Clin North Am 2008;37:525–38, xi doi:10.1016/j.ecl.2008.02.003 pmid:18502341

   CrossRefPubMed
9. 9.↵
   2. Mohebati A,
   3. Dilorenzo M,
   4. Palmer F, et al

   . Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol 2014;21:1665–70 doi:10.1245/s10434-014-3545-5 pmid:24554064

   CrossRefPubMed
10. 10.↵
    2. Haddad RI,
    3. Lydiatt WM,
    4. Ball DW, et al

    . Anaplastic thyroid carcinoma, version 2.2015. J Natl Compr Canc Netw 2015;13:1140–50 doi:10.6004/jnccn.2015.0139 pmid:26358798

    Abstract/FREE Full Text
11. 11.↵
    2. Hahn SY,
    3. Shin JH

    . Description and comparison of the sonographic characteristics of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. J Ultrasound Med 2016;35:1873–79 doi:10.7863/ultra.15.09058 pmid:27388812

    Abstract/FREE Full Text
12. 12.↵
    2. Cabanillas ME,
    3. McFadden DG,
    4. Durante C

    . Thyroid cancer. Lancet 2016;388:2783–95 doi:10.1016/S0140-6736(16)30172-6 pmid:27240885

    CrossRefPubMed
13. 13.↵
    2. Ain KB

    . Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999;16:64–69 doi:10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.0.CO%3B2-U pmid:9890741

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Kelil T,
    3. Keraliya AR,
    4. Howard SA, et al

    . Current concepts in the molecular genetics and management of thyroid cancer: an update for radiologists. Radiographics 2016;36:1478–93 doi:10.1148/rg.2016150206 pmid:27618325

    CrossRefPubMed
15. 15.↵
    2. Ishikawa H,
    3. Tamaki Y,
    4. Takahashi M, et al

    . Comparison of primary thyroid lymphoma with anaplastic thyroid carcinoma on computed tomographic imaging. Radiat Med 2002;20:9–15 pmid:12002606

    PubMed
16. 16.↵
    2. Takashima S,
    3. Morimoto S,
    4. Ikezoe J, et al

    . CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol 1990;154:1079–85 doi:10.2214/ajr.154.5.2108546 pmid:2108546

    CrossRefPubMed
17. 17.↵
    2. Lee JW,
    3. Yoon DY,
    4. Choi CS, et al

    . Anaplastic thyroid carcinoma: computed tomographic differentiation from other thyroid masses. Acta Radiol 2008;49:321–27 doi:10.1080/02841850701813120 pmid:18365821

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Kim TY,
    3. Kim KW,
    4. Jung TS, et al

    . Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 2007;29:765–72 doi:10.1002/hed.20578 pmid:17274052

    CrossRefPubMed
19. 19.↵
    2. Smallridge RC,
    3. Marlow LA,
    4. Copland JA

    . Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 2009;16:17–44 doi:10.1677/ERC-08-0154 pmid:18987168

    Abstract/FREE Full Text
20. 20.↵
    2. Us-Krasovec M,
    3. Golouh R,
    4. Auersperg M, et al

    . Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol 1996;40:953–58 doi:10.1159/000334007 pmid:8842172

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Kim DW

    . Computed tomography features of papillary thyroid carcinomas. J Comput Assist Tomogr 2014;38:936–40 doi:10.1097/RCT.0000000000000149 pmid:25229203

    CrossRefPubMed
22. 22.↵
    2. Molinaro E,
    3. Romei C,
    4. Biagini A, et al

    . Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol 2017;13:644–60 doi:10.1038/nrendo.2017.76 pmid:28707679

    CrossRefPubMed